Multimodal molecular testing with GEP and #ddcfDNA predicts future graft dysfunction and cardiovascular death in #HeartTransplant recipients. @KiranKhush1
🔗: jhltonline.org/article/S1053…
Ashwin R retweeted
We are ready for integration of cardiac energetics into routine care:
Bedside Integration of VA Coupling, Cardiac Energetics, and Advanced Hemodynamics in the Management of Heart Failure - JCF - Intersections onlinejcfi.org/article/S3050…
@JCFINT @JasonKatzMD @MarkBelkinMD
Ashwin R retweeted
When you show up for clinic and you and your #AHFTC fellow and you are #twinning @StVincentIN @StVHeartCenter @StVCardsFellows #ACCWIC @shwinner
Our latest analysis from the SHORE registry now in @TheJHLT comprised of nearly 2000 pts with heart transplant
Read here about the risk of dual + GEP/dd-cfDNA
jhltonline.org/article/S1053…
@JeffTeuteberg @KiranKhush1 @CareDx
☎️ out to all critical care cardiologists ❤️- looking for some shock ⚡️, transplant and MCS inclined 🧑⚕️ 👩⚕️ 👨⚕️ to join our squad @StVincentIN. Please contact myself or @SunitChaudhryMD if you want to learn more!
providerjobs-ascension.icims…
Ashwin R retweeted
Heart transplant doc here - I and my whole family) are organ donors.
Don’t let stories or one offs take away from one of medicine truly great accomplishments.
#giftoflife
@AndrewJSauer @JasonKatzMD @shwinner @robmentz @ShashankSinhaMD @JonGrinsteinMD
Fantastic program to be a part of - really appreciate being able to participate in the education of the future of our field!
Congratulations to the ASCEND fellows! Thank you to the faculty who participated and shared their wisdom and experience over the last three programs. A special thanks to @shelleyhallmd @JeffTeuteberg and @AHajduczok for their passion and leadership!
Ashwin R retweeted
Thank you ASCEND fellows and faculty for the wonderful conversations today focused on clinical cases. Special thanks to the amazing faculty and our Course Directors.
#heartfailure @shelleyhallmd @JeffTeuteberg @AHajduczok @shwinner @RajeevCMohan @amarinderbindra
Thank you to the ASCEND faculty and fellows for their impactful contributions in today’s virtual case review. Your dedication to sharing real-world experience continues to advance the field of #heartfailure and improve patient care.
We look forward to continuing to support this important work!
Faculty: Drs. @AHajduczok, @shelleyhallmd, @JeffTeuteberg, Amarinder Bindra, Ashwin Ravichandran, @RajeevCMohan
Ashwin R retweeted
Thrilled to announce that the one and only @JasonKatzMD will be the new Editor in Chief of JCF Intersections!
Excited to see all the incredible things he and the team accomplish as part of the @JCardFail Family
Let's do this! 🍾
@dranulala @ShashankSinhaMD @HFSA @DrMarthaGulati
📣@HFSA & @ELS_Cardiology announce Dr. Jason N. Katz as the inaugural Editor-in-Chief of the Journal of Cardiac Failure-Intersections!
@JasonKatzMD will guide its mission to advance knowledge in #heartfailure and other disciplines in the cardiovascular community. #CardioTwitter
Our why, and our honor, @Eli778813! @SunitChaudhryMD @KayMorrisMong @old_joshidoc @drparinpatel @BradClarkEP @GilgeJasen
Thankful for the great doctors @StVHeartCenter @StVincentIN
I had an implant for an LVAD on 9/23/2024. 4 and half months later I am doing what I love reffing basketball, and playing golf.
@shwinner @AnotherAPatelMD @rs_gc @MinnowWalsh
Ashwin R retweeted
One Love. 🫶
1 RT = 2 Votes for our Walter Payton Man of the Year
#WPMOYChallenge
onlinelibrary.wiley.com/doi/…
Long time 🕰️ coming! 🫁 🫀 - treating PAH post LVAD works with Macitentan 💊!
@StVincentIN
@ShashankDesai08 @StacyMandras @RyanTedfordMD @SusanJosephMD @rcogswell_umn @SunitChaudhryMD @MinnowWalsh @MikeMathier @KayMorrisMong @old_joshidoc
So excited to share some thoughts on “Contemporary LVAD Management: A Marathon, Not a Sprint” on Saturday Sep 28, 2024 2:45 PM - 3:45 PM (ET). The world’s HF teams gather together
#HFSA2024! @SunitChaudhryMD @MinnowWalsh @old_joshidoc @dranulala @rcogswell_umn @KayMorrisMong
Ashwin R retweeted
The DOAC LVAD (Evaluation of the Hemocompatibility of the DOAC Apixaban vs Warfarin in LVAD) Phase II RCT out! DOAC was safe without an excess of HRAEs or deaths
jacc.org/doi/10.1016/j.jchf.… @JACCJournals #JACCHF @coconnormd @PalakShahMD @ShashankSinhaMD
We work with a fantastic group huh? @SunitChaudhryMD @old_joshidoc @AnotherAPatelMD @rs_gc @KayMorrisMong @BradClarkEP @drparinpatel @MinnowWalsh
When carefully selected, you can sent patients home same day after ventricular ablations. @drparinpatel @old_joshidoc @BradClarkEP @justinbfield @ashah1988 @StVincentIN @PadanilamBenzy @mathewpadanilam
url.us.m.mimecastprotect.com…
Ashwin R retweeted
IN PRESS NOW 🚨 @JCardFail
What are the current challenges of LVAD implementation in Latin America?
Read HFC members @vbluml @Chguilliod article about LVAD landscape and future direction at link below ⬇️
doi.org/10.1016/j.cardfail.2…
Honored to be able to participate in this important project! @SunitChaudhryMD @MinnowWalsh @old_joshidoc @drparinpatel @BradClarkEP @GilgeJasen @rs_gc @AnotherAPatelMD @KayMorrisMong
resmedjournal.com/article/S0…
Ashwin R retweeted
Applying for AHFTC Fellowship this year? Come join us at CPMC in San Francisco where you will obtain strong comprehensive clinical training in temp/durable MCS, HTx and CV shock ! suttermd.com/education/fello…
@shwinner @JonathanDavisHF @ajaysmd @MichaelTongMD
Ashwin R retweeted
Excited to have been a part of this!
apnews.com/press-release/pr-…





























